Overview
Fine Needle Aspiration of Liver, Gastrointestinal Tract, and Pancreatic Lesions
Biliary Duct Brushings
Nonalcoholic Fatty Liver Disease/NASH
Liver Fibrogenesis
Current Appointments & Affiliations
Professor of Pathology
·
2021 - Present
Pathology,
Clinical Science Departments
Professor of Medicine
·
2020 - Present
Medicine, Gastroenterology,
Medicine
Recent Publications
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials.
Journal Article J Hepatol · October 8, 2025 BACKGROUND & AIMS: Assessment of histologic disease activity (grading) and fibrosis (staging) is a prerequisite for patient selection and evaluation of treatment response in clinical trials of metabolic dysfunction-associated steatohepatitis (MASH). The la ... Full text Link to item CiteClinical associations of portal-based disease in MASLD: proposal of a new histological scoring system.
Journal Article Virchows Arch · August 2025 Portal inflammation (PI) and ductular reaction (DR) in metabolic dysfunction-associated steatotic liver disease (MASLD) have shown associations with disease severity. We developed a histologic categorization of these features to correlate with known featur ... Full text Link to item CiteIdentification of Potential Therapeutic Targets Against Anthrax-Toxin-Induced Liver and Heart Damage.
Journal Article Toxins (Basel) · January 24, 2025 Anthrax represents a disease resulting from infection by toxin-secreting bacteria, Bacillus anthracis. This research aimed to identify new therapeutic targets to combat anthrax. We performed assays to assess cell viability, apoptosis, glycogen consumption, ... Full text Link to item CiteRecent Grants
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
ResearchPathologist · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2004 - 2027A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
ResearchCollaborating Investigator · Awarded by Mayo Clinic - Rochester · 2022 - 2025A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
ResearchCollaborating Investigator · Awarded by Department of Defense · 2020 - 2023View All Grants
Education, Training & Certifications
Medical University of South Carolina, College of Medicine ·
1993
M.D.
University of North Carolina, Chapel Hill ·
1985
B.A.